Generated by Yoast SEO v26.3, this is an llms.txt file, meant for consumption by LLMs. The XML sitemap of this website can be found by following [this link](https://www.worldwide.com/sitemap_index.xml). # Worldwide Clinical Trials > Worldwide Clinical Trials is a top\-rated, full\-service global CRO\. We provide 30\+ years of clinical expertise to benefit your study\. Learn more about us here\. ## Pages - [About Us](https://www.worldwide.com/about-us/) - [Contact Us](https://www.worldwide.com/contact-us/) - [Privacy at Worldwide](https://www.worldwide.com/privacy-statement-terms-of-use/) - [Online Privacy Statement](https://www.worldwide.com/privacy-statement-terms-of-use/online-privacy-statement/) - [Cardiovascular \& Metabolic](https://www.worldwide.com/expertise/cardiovascular-metabolic/) - [Immune Mediated Inflammatory Diseases](https://www.worldwide.com/expertise/immune-mediated-inflammatory-diseases/) - [Neuroscience](https://www.worldwide.com/expertise/neuroscience/) - [Rare Disease](https://www.worldwide.com/expertise/rare-disease/) - [Cell \& Gene Therapy](https://www.worldwide.com/expertise/cell-gene-therapy/) - [Global Reach](https://www.worldwide.com/global-reach/) ## Posts - [Strategic Site Selection Accelerates Enrollment in Migraine Safety Study](https://www.worldwide.com/blog/2026/07/migraine-enrollment-case-study/) - [Tech\-Enabled FSP Delivery: What’s Changed \& Why It Matters for Trial Readiness](https://www.worldwide.com/blog/2026/07/tech-enabled-fsp-clinical-trial-readiness/) - [Adapting Without Hesitation: How Worldwide Clinical Trials Delivered a Large\-Scale Phase III Analgesic Study Under Pressure](https://www.worldwide.com/blog/2026/07/acute-low-back-pain-phase-iii-clinical-trial/) - [Beyond the Data: Translating Five Insights from ASCO 2026 into Strategic Trial Development \& Execution](https://www.worldwide.com/blog/2026/07/asco-key-oncology-insights-2/) - [AI, Open Source, \& the Future of Biostatistics](https://www.worldwide.com/blog/2026/07/ai-open-source-tools-clinical-biostatistics/) ## Articles - [Worldwide Contributes to Broad\-Led Initiative Advancing Rare Disease Research](https://www.worldwide.com/newsroom/arpa-h-pediatric-epilepsy-gene-editing-consortium/) - [Worldwide Clinical Trials Enters into a Strategic Collaboration with Invitae to Accelerate Clinical Trials for Rare Disease Patients](https://www.worldwide.com/newsroom/worldwide-enters-into-collaboration-with-invitae/) - [Worldwide Clinical Trials Launches ‘Rare Moments’ Website, Giving Rare Disease Patients, Family Members, Researchers, and Supporters the Opportunity to Share Transformative Experiences and Build Community](https://www.worldwide.com/newsroom/worldwide-clinical-trials-launches-rare-moments/) - [Recruitment and Retention in Rare Disease Studies: The Integral Role of Genetic Counselors](https://www.worldwide.com/newsroom/recruitment-and-retention-in-rare-disease-studies/) - [Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence](https://www.worldwide.com/newsroom/worldwide-clinical-trials-medidata-partnership-medidata-ai/) ## Team - [Gijsbert Veerman](https://www.worldwide.com/about-us/meet-the-team/gijsbert-veerman/): 30\+ years in clinical research with expertise in early phase oncology, advancing innovative cancer therapies and clinical strategy\. - [Marcin Ernst, MD, MBA](https://www.worldwide.com/about-us/meet-the-team/marcin-ernst/) - [Martin Cummins](https://www.worldwide.com/about-us/meet-the-team/martin-cummins/): Executive clinical operations leader with 30\+ years’ experience delivering Phase 1–4 trials across rare diseases, gene therapy, autoimmune, endocrine, and pulmonary programs\. - [Stefan Comhaire](https://www.worldwide.com/about-us/meet-the-team/stefan-comhaire/): Nephrology clinical trials leader with 24 years’ pharmaceutical industry experience overseeing renal and rare renal study portfolios\. - [Rafal Ziecina, MD, PhD](https://www.worldwide.com/about-us/meet-the-team/rafal-ziecina/): Executive Director of Scientific Solutions with 20\+ years’ pharmaceutical research experience leading cardiovascular and metabolic initiatives, regulatory strategy, safety, and development planning\. ## Events - [Medidata NEXT Innovation Tokyo](https://www.worldwide.com/events/medidata-next-innovation-tokyo/) - [IPF Summit 2026](https://www.worldwide.com/events/ipf-summit-2026/) - [Applied Pharmaceutical Analysis \(APA\) 2026](https://www.worldwide.com/events/applied-pharmaceutical-analysis-apa-2026/) - [SCDM 2026](https://www.worldwide.com/events/scdm-2026/) - [Clinical Trials in Rare Diseases 2026](https://www.worldwide.com/events/clinical-trials-in-rare-diseases-2026/) ## Insights - [The Role of Non\-Invasive Tests in MASH Drug Development Decision Making](https://www.worldwide.com/insights/non-invasive-tests-mash-drug-development-solar-2026/) - [Engaging with Rare Oncology Research Consortia: Forging Meaningful Relationships](https://www.worldwide.com/insights/rare-oncology-disease-consortia-in-clinical-research/) - [Early Phase Transition Study In a Progressive Rare Disease: A Personal Approach](https://www.worldwide.com/insights/early-phase-rescue-study-in-progressive-rare-disease/) - [8 Frequently Asked Questions About Genetic Testing in Clinical Trials](https://www.worldwide.com/insights/genetic-testing-in-clinical-trials-benefits-faqs-best-practices/) - [A Novel Approach to Early Phase Studies for Advanced Therapeutics](https://www.worldwide.com/insights/early-phase-studies-recruiting-rare-disease-participants/) ## Categories - [Press Releases](https://www.worldwide.com/newsroom-category/press-releases/) - [In The News](https://www.worldwide.com/newsroom-category/in-the-news/)